Molecular mechanisms of cisplatin resistance

Galluzzi, L, Senovilla, L, Vitale, I, Michels, J, Martins, I, Kepp, O, Castedo, M, Kroemer, G·2012·Oncogene

DOI 10.1038/onc.2011.384

Cited by (1,001)

Items 501–600 of 1,001

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
Ran Wang, Xinxing Lu, Riyue Yu · 2020 · OncoTargets and Therapy
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
Veronica Cocetta, Vincenzo Quagliariello, Francesco Fiorica, Massimiliano Berretta, Monica Montopoli · 2021 · International Journal of Molecular Sciences
CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation
Zhenchuan Liu, Shaorui Gu, Kaiqin Wu, Lei Li, Chenglai Dong, Wenli Wang, Yongxin Zhou · 2021 · Journal of Experimental & Clinical Cancer Research
GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway
Hua-wen Li, Mubiao Liu, Xue Jiang, Ting Song, Shuxian Feng, Jingya Wu, Pengfei Deng, Xiaoyu Wang · 2021 · Future Oncology
Molecular mechanisms associated with chemoresistance in esophageal cancer
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, Luís Felipe Ribeiro Pinto, Nathalia Meireles Da Costa, Antônio Palumbo · 2022 · Cellular and Molecular Life Sciences
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
Caterina Vianello, Veronica Cocetta, Daniela Catanzaro, Gerald W. Dorn, Angelo De Milito, Flavio Rizzolio, Vincenzo Canzonieri, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli et al. · 2022 · Cell Death and Disease
Defining the metal binding pathways of human metallothionein 1a: balancing zinc availability and cadmium seclusion
Gordon W. Irvine, Tyler B. J. Pinter, Martin J. Stillman · 2015 · Metallomics
Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
Winyoo Chowanadisai, Shanta M. Messerli, Daniel H. Miller, Jamie E. Medina, Joshua W. Hamilton, Mark A. Messerli, Alexander S. Brodsky · 2016 · PLoS ONE
Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview
Dietrich Büsselberg, Ana‐Maria Florea · 2017 · Cancers
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma
Anthony M. Robinson, Richa Rathore, Nathan J. Redlich, Douglas R. Adkins, Todd L. VanArsdale, Brian Andrew Van Tine, Loren Scott Michel · 2019 · Cell Death and Disease
Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium( iv ) complexes: DNA/HSA interaction, cytotoxic activity and DFT studies
Atanu Banerjee, Monalisa Mohanty, Sudhir Lima, Rajib Samanta, Eugenio Garribba, Takahiro Sasamori, Rupam Dinda · 2020 · New Journal of Chemistry
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications
Erika Vacchelli, Jonathan G. Pol, Norma Bloy, Alexander M.M. Eggermont, Isabelle Cremer, Wolf H. Fridman, Jérôme Galon, Aurélien Marabelle, Holbrook E K Kohrt, Laurence Zitvogel et al. · 2015 · OncoImmunology
Novel Bis-Thiazole Derivatives: Synthesis and Potential Cytotoxic Activity Through Apoptosis With Molecular Docking Approaches
Kamal Mohamed Dawood, Mohamed Abd-Elmonem Raslan, Ashraf A. Abbas, Belal E. Mohamed, Magda H. Abdellattif, Mohamed S. Nafie, Mohamed Kamel Hassan · 2021 · Frontiers in Chemistry
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
Meysam Moghbeli · 2021 · Journal of Ovarian Research
Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism
Yajun Luo, Wanping Xiang, Haohuan Li, Yao Lin, Linghan Tang, Tan Wang, Pengcheng Ye, Jingyu Deng, Jiangwei Xiao · 2022 · Free Radical Biology and Medicine
New developments in the treatment of ovarian cancer—future perspectives
Juanita Suzanne Lopez, Susana N. Banerjee, Stuart B. Kaye · 2013 · Annals of Oncology
A dual role for Caspase8 and NF-κB interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival
Luis Alberto Parra Hernández, Meyoung-kon Kim, Anne M. Noonan, Ethan Sagher, Holger Kohlhammer, George W. Wright, L. Tiffany Lyle, Patricia Schriver Steeg, Miriam R. Anver, David D.L. Bowtell et al. · 2015 · Cell Death Discovery
p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer
Xiao‐Yu Yan, Xinru Zhong, Sihang Yu, Li‐Chao Zhang, Yanan Liu, Yong Zhang, Liankun Sun, Jing Su · 2019 · Journal of Cellular and Molecular Medicine
Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}
Zeenat Afsan, Thierry Roisnel, Sartaj Tabassum, Farukh Arjmand · 2019 · Bioorganic Chemistry
Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway
Xiaozhong Liao, Ying Gao, Hongwei Zhao, Mi Zhou, Danlei Chen, Lan-Ting Tao, Wei Guo, Lingling Sun, Chuying Gu, Hanrui Chen et al. · 2021 · Frontiers in Cell and Developmental Biology
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
Claudia S. Schmidt, Tomer Babu, Hana Kostrhunová, Annika Timm, Uttara Basu, Ingo Ott, Valentina Gandin, Viktor Brabec, Dan Gibson · 2021 · Journal of Medicinal Chemistry
MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells
Mingqi Wang, Renwen Zhang, Shu Zhang, Rui Xu, Qing Yang · 2019 · Gene
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p–MFF axis
Song Fan, Bodu Liu, Lijuan Sun, Xiaobin Lv, Zhaoyu Lin, Weixiong Chen, Wei‐liang Chen, Qiong-Lan Tang, Youyuan Wang, Yu‐Xiong Su et al. · 2015 · Oncotarget
MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells
Jean‐Philippe Guégan, Frédéric Ezan, Nathalie Théret, Sophie Langouët, Georges Baffet · 2012 · Carcinogenesis
Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling
Huan Yan, Bi-Ying Guo, Shu Zhang · 2016 · Biochemical and Biophysical Research Communications
“Half-sandwich” Schiff-base Ir(III) complexes as anticancer agents
Ze‐Dong Mou, Ning Deng, Feng Zhang, Jiaying Zhang, Juan Cen, Xia Zhang · 2017 · European Journal of Medicinal Chemistry
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Ratnakar Singh, Zeeshan Fazal, Sarah J. Freemantle, Michael J. Spinella · 2019 · Cancer Drug Resistance
Imaging and therapeutic applications of Zn( ii )-cryptolepine–curcumin molecular probes in cell apoptosis detection and photodynamic therapy
Qi‐Pin Qin, Zu‐Zhuang Wei, Zhenfeng Wang, Xiaoling Huang, Ming‐Xiong Tan, Hua‐Hong Zou, Hong Liang · 2020 · Chemical Communications
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents
Rui‐Rong Ye, Cai‐Ping Tan, Bi-Chun Chen, Rong‐Tao Li, Zong‐Wan Mao · 2020 · Frontiers in Chemistry
Photoactivated Nanosheets Accelerate Nucleus Access of Cisplatin for Drug‐Resistant Cancer Therapy
Fang Gao, Xue Yang, Xinping Luo, Xuling Xue, Chenggen Qian, Minjie Sun · 2020 · Advanced Functional Materials
G3BP1 Interacts with YWHAZ to Regulate Chemoresistance and Predict Adjuvant Chemotherapy Benefit in Gastric Cancer
Junjie Zhao, Xuhong Fu, Hao Chen, Lingqiang Min, Jie Sun, Jingyi Yin, Jianping Guo, Haojie Li, Zhaoqing Tang, Yuanyuan Ruan et al. · 2019 · British Journal of Cancer
Trial Watch: Radioimmunotherapy for oncological indications
Norma Bloy, Jonathan G. Pol, Gwenola Manic, Ilio Vitale, Alexander M.M. Eggermont, Jérôme Galon, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2014 · OncoImmunology
Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2
Sha Huang, Tianyu He, Sijia Yang, Hongxu Sheng, Xiuwen Tang, Feichao Bao, Yiqing Wang, Xu Lin, Wenfeng Yu, Fei Cheng et al. · 2020 · Translational Lung Cancer Research
Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss
Bingquan Jian, Jiaqi Pang, Hao Xiong, Weijian Zhang, Ting Zhan, Zhongwu Su, Hanqing Lin, Huasong Zhang, Wuhui He, Yiqing Zheng · 2021 · Toxicology Letters
YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer
Yinjie Su, Bo Wang, Jian Hua Huang, Ming Xing Huang, Tianxin Lin · 2023 · Cell Proliferation
Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer
Xiangpeng Wang, Yurong Song, Liuchunyang Yu, Xiaoxia Xue, Mingshi Pang, Yang Li, Xinyi Luo, Zhenglai Hua, Cheng Chang Lu, Aiping Lü et al. · 2023 · ACS Applied Materials & Interfaces
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, Leonie Kurek, Johannes Karges, Robert B. Macgregor, Maryam Saeidifar, Irena P. Kostova, Ali Akbar Saboury · 2023 · Journal of Molecular Structure
MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer
Ying Chen, Yanping Gao, Kai Zhang, Chen Li, Yan Pan, Jing Chen, Rui Wang, Longbang Chen · 2015 · Cellular Physiology and Biochemistry
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
Wei Jiang, Yue Yan, Manyu Chen, Guangyu Luo, Jiaojiao Hao, Jinjin Pan, Sheng Chuan Hu, Ping Guo, Wenyang Li, Ruozu Wang et al. · 2020 · Aging
Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress
Wangjie Yu, Yunyun Chen, Nagireddy Putluri, Cristian Coarfa, Matthew J. Robertson, Vasanta Putluri, Fabio Stossi, Julien Dubrulle, Michael A. Mancini, Jonathan C. Pang et al. · 2020 · Cancers
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
Nur Aininie Yusoh, Haslina Ahmad, Martin R. Gill · 2020 · ChemMedChem
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
Jing Guo, Kiyotoshi Satoh, Sho Tabata, Masaru Mori, Masaru Tomita, Tomoyoshi Soga · 2021 · BMC Cancer
Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells
Seung Un Seo, Seon Min Woo, Seung‐Soon Im, Younghoon Jang, Eugene Han, Sang Hyun Kim, Hongchan Lee, Hyun‐Shik Lee, Ju‐Ock Nam, Edward W. Gabrielson et al. · 2022 · Cell Death and Disease
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
Se Jin Oh, Ji Yeon Lim, Min Kyu Son, Jun Hyeok Ahn, Kwon‐Ho Song, Hyo‐Jung Lee, Suyeon Kim, Eunho Cho, Joon‐Yong Chung, Hanbyoul Cho et al. · 2023 · Nature Communications
An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management
Caroline Assunção Oliveira, Érika Azenathe Barros Mercês, Fernanda Santos Portela, Lara Fabiana Luz Malheiro, Henrique Bruno Lopes Silva, Laís Mafra De Benedictis, Júlia Mafra De Benedictis, Clara Cotta d’Ávila e Silva, Alberto Christian Luz Santos, Dã Pinheiro Rosa et al. · 2024 · Clinical and Experimental Nephrology
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells
Elisa Caiola, Daniela Correia Salles, Roberta Frapolli, Monica Lupi, Giuseppe Rotella, Anna Ronchi, Marina Chiara Garassino, Nikola Anna Luise Mattschas, Stefano Colavecchio, Massimo Broggini et al. · 2015 · Oncotarget
Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer
Tao Wang, Zi Liu, Fan Shi, Jiquan Wang · 2016 · Molecular and Cellular Biochemistry
GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells
I‐Lun Hsin, Chu‐Chyn Ou, Ming‐Fang Wu, Ming‐Shiou Jan, Yi‐Min Hsiao, Ching‐Hsiung Lin, Jiunn‐Liang Ko · 2015 · Molecular Pharmaceutics
Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
Shouhai Wu, Tianpeng Zhang, Jingsheng Du · 2016 · Drug Design Development and Therapy
Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro
Ahmad Zaim Mat Pauzi, Swee Keong Yeap, Nadiah Abu, Kian Lam Lim, Abdul Rahman Omar, Suraini Abd. Aziz, Adam Leow Thean Chow, Tamilselvan Subramani, Soon Guan Tan, Noorjahan Banu Alitheen · 2016 · Chinese Medicine
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
Jolein Mijnes, Jürgen Veeck, Nadine Therese Gaisa, Eduard Burghardt, Tim C. de Ruijter, Sonja Gostek, Edgar Dahl, David Johannes Karl Paul Pfister, Sebastian Christoph Schmid, Ruth Knüchel et al. · 2018 · Clinical Epigenetics
The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
Qi Wu Shi, Luyan Shen, Bin Dong, Hao Fu, Xiaozheng Kang, Yongbo Yang, Liang Xiang Dai, Wanpu Yan, Hongchao Xiong, Zhen Liang et al. · 2018 · Cancer Letters
Imine‐N‐Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p‐Cymene Anticancer Complexes: A Structure–Activity Relationship Study
Yuliang Yang, Lihua Guo, Zhenzhen Tian, Xicheng Liu, Yuteng Gong, Hongmei Zheng, Xingxing Ge, Zhe Liu · 2018 · Chemistry - An Asian Journal
Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications
Avijita Jain · 2019 · Coordination Chemistry Reviews
Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin
Jia Guo, Zhang Jiangling, Long Liang, Nian Liu, Min Qi, Shuang Zhao, Juan Su, Jing Liu, Cong Peng, Xiang Chen et al. · 2020 · Journal of Cellular and Molecular Medicine
Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis
Ziyu Cheng, Zhihui Li, Ling Gu, Liqiu Li, Qian Gao, Xiong‐Fei Zhang, Jin Fu, Yuanyuan Guo, Qirui Li, Xu Shen et al. · 2022 · Journal of Cancer
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
Sandra Cotino‐Nájera, Luis A. Herrera, Guadalupe Domínguez-Gómez, José Díaz‐Chávez · 2023 · Frontiers in Pharmacology
Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death
Yu‐Qiang Zhao, Le Yu, Lanyun Zhang, Huan Liu, Ying Mei Zhou, Jong Seung Kim · 2024 · Aggregate
Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma
Rebeca Kawahara, Daniela C. Granato, Carolina Moretto Carnielli, Nilva K. Cervigne, Carine E Oliveria, César A R Martinez, Sami Yokoo, Felipe Paiva Fonseca, Márcio Ajudarte Lopes, Alan Roger Santos‐Silva et al. · 2014 · PLoS ONE
Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application
Ludmila Boublíková, Tomáš Büchler, Jan Starý, Jitka Abrahámová, Jan Trka · 2013 · Critical Reviews in Oncology/Hematology
The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells
Ping Chen, Jian Li, Yongchang Chen, Hai Qian, Yu-Jiao Chen, Jinyu Su, Min Cong Wu, Ting Lan · 2016 · Cellular Oncology
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
Issam Chebouti, Jan Dominik Kuhlmann, Paul Buderath, Stephan Weber, Pauline Wimberger, Yvonne Bokeloh, Siegfried Hauch, Rainer Kimmig, Sabine Kasimir‐Bauer · 2016 · Oncotarget
Melatonin and non-small cell lung cancer: new insights into signaling pathways
Mohammad Hossein Pourhanifeh, Mehran Sharifi, Russel Joseph Reiter, Abdoulhossein Davoodabadi, Zatollah Asemi · 2019 · Cancer Cell International
Nephroprotective effect of umbelliferone against cisplatin‐induced kidney damage is mediated by regulation of NRF2, cytoglobin, SIRT1/FOXO‐3, and NF‐ k B‐p65 signaling pathways
Fares E.M. Ali, Emad H. M. Hassanein, Ali H. El‐Bahrawy, Zainab Mohammed Mahmoud Omar, Eman K. Rashwan, Basel A. Abdel‐Wahab, Tarek Hamdy Abd‐Elhamid · 2021 · Journal of Biochemical and Molecular Toxicology
Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p-Cymene Complexes
Moumita Maji, Sourav Acharya, Indira Bhattacharya, Arnab Gupta, Arindam Mukherjee · 2021 · Inorganic Chemistry
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies
Carlo Marotta, Ester Giorgi, Francesca Binacchi, Damiano Cirri, Chiara Gabbiani, Alessandro Pratesi · 2023 · Inorganica Chimica Acta
The Importance of Being Casiopeina as Polypharmacologycal Profile (Mixed Chelate–Copper (II) Complexes and Their In Vitro and In Vivo Activities)
Zenayda Aguilar-Jiménez, Adrián Espinoza-Guillén, Karen Reséndiz-Acevedo, Inés Fuentes-Noriega, Carmen Mejía, Lena Ruíz-Azuara · 2023 · Inorganics
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
Hind Ray, Yves Roméo, Geneviève Lavoie, Paul Déléris, Joseph Tcherkezian, Jacob Anthony Galan, Philippe P. Roux · 2012 · Oncogene
Victories and deceptions in tumor immunology
Guido Kroemer, Laurence Zitvogel, Lorenzo Galluzzi · 2013 · OncoImmunology
One-Pot Synthesis of Mesoporous Silica Nanocarriers with Tunable Particle Sizes and Pendent Carboxylic Groups for Cisplatin Delivery
Jinlou Gu, Jiapeng Liu, Yongsheng Li, Wenru Zhao, Jianlin Shi · 2012 · Langmuir
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
Li Ren Kong, Kian Ngiap Chua, Wen Jing Sim, Hsien Chun Ng, Chonglei Bi, Jingshan Ho, Min En Nga, Yin Huei Pang, Weijie Richard Ong, Ross Andrew Soo et al. · 2015 · Molecular Cancer Therapeutics
MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR
Zhe Zhu, Cun-Ping Wang, Yinfeng Zhang, Lin Nie · 2014 · Asian Pacific Journal of Cancer Prevention
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
Shinya Matsuzaki, Kiyoshi Yoshino, Yutaka Ueda, Satoko Matsuzaki, Mamoru Kakuda, Akiko Okazawa, Tomomi Egawa‐Takata, Eiji Kobayashi, Tadashi Kimura · 2015 · Cancer Cell International
Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor
Jeewon Kim, June Ho Shin, Che‐Hong Chen, Leslie A. Cruz, Lovisa Farnebo, Jieying Yang, Paula Borges, Gugene Kang, Daria Mochly‐Rosen, John B. Sunwoo · 2017 · Oncotarget
Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ
Ting Zhan, Xiaodong Huang, Tian Xia, Xiaoli Chen, Yu Ding, Hesheng Luo, Yadong Zhang · 2017 · Molecular Therapy — Nucleic Acids
Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex
David Schlütermann, Margaretha A. Skowron, Niklas Berleth, Philip Böhler, Jana Deitersen, Fabian Stuhldreier, Nora Hieke, Wenxian Wu, Christoph Peter, Michèle J. Hoffmann et al. · 2017 · Urologic Oncology Seminars and Original Investigations
Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells
Zahre Sajadpoor, Zeinab Amini‐Farsani, Hossein Teimori, Mehdi Shamsara, Mohammad Hossein Sangtarash, Payam Ghasemi-Dehkordi, Farrokh Yadollahi · 2018 · Applied Biochemistry and Biotechnology
Development of an Efficient Dual‐Action GST‐Inhibiting Anticancer Platinum(IV) Prodrug
Keefe Guang Zhi Lee, Maria V. Babak, Andrea Weiss, Paul J. Dyson, Patrycja M. Nowak-Sliwinska, Diego Montagner, Wee Han Ang · 2018 · ChemMedChem
Rapid Microwave-Assisted Cisplatin-Loaded Solid Lipid Nanoparticles: Synthesis, Characterization and Anticancer Study
Hibah Mubarak Aldawsari, Sima Singh · 2020 · Nanomaterials
Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
Cinzia Calcabrini, Francesca Maffei, Eleonora Turrini, Carmela Fimognari · 2020 · Frontiers in Pharmacology
Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapy
Han Yang, Bo Sun, Hong Cai, Yi Xuan · 2021 · Cancer Immunology Immunotherapy
Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated Cisplatin
Svenja Siemer, Tobias Alexander Bauer, Paul Scholz, Christina Breder, Federico Fenaroli, Gregory S. Harms, Dimo Dietrich, Jörn Dietrich, Christine Rosenauer, Matthias Barz et al. · 2021 · ACS Nano
pH-Responsive Liposomes of Dioleoyl Phosphatidylethanolamine and Cholesteryl Hemisuccinate for the Enhanced Anticancer Efficacy of Cisplatin
Hassan Shah, Asadullah Madni, Muhammad Muzamil Khan, Fiaz-ud-Din Ahmad, Nasrullah Jan, Safiullah Khan, Muhammad Abdur Rahim, Shahzeb Khan, Meser M. Ali, Mohsin Kazi · 2022 · Pharmaceutics
Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis
Ye Xu, Chunyan Wang, Jing Su, Qi Xie, Liwei Ma, Linchuan Zeng, Yang Yu, SHIBING LIU, SONGYAN LI, Zhixin Li et al. · 2015 · Oncology Reports
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy
Weimin Gao, Chuanwen Lu, Lixia Chen, Phouthone Keohavong · 2015 · Journal of Thoracic Oncology
Decitabine reactivated pathways in platinum resistant ovarian cancer
Fang Fang, Qingyao Zuo, Jay M. Pilrose, Yinu Wang, Changyu Shen, Meng Li, Phillip Wulfridge, Daniela Elena Matei, Kenneth P. Nephew · 2014 · Oncotarget
Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress
Jun Lü, Jian Chen, Nianjun Xu, Jun Fa Wu, Yani Kang, Tingting Shen, Hualei Kong, Chao Ma, Ming Y. Cheng, Zhifeng Shao et al. · 2016 · Toxicology Letters
Platinum drugs, copper transporters and copper chelators
Fabio Arnesano, Maria Incoronata Nardella, Giovanni Natile · 2018 · Coordination Chemistry Reviews
Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells
Mădălina Andreea Badea, Mariana Prodana, Anca Dinischiotu, Carmen Crihana, Daniela Ioniță, Mihaela Balaș · 2018 · Pharmaceutics
Luminescent anticancer ruthenium( ii )- p -cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging
Bidisha Sarkar, Ashaparna Mondal, Yukti Madaan, Nilmadhab Roy, Anbalagan Moorthy, Yung‐Chih Kuo, Priyankar Paira · 2019 · Dalton Transactions
Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites
Qian Wen, Yan Zhang, Jia Luo, Kang Xiong, Yun Lü, Zhouxue Wu, Bi Qiong Wang, Jingbo Wu, Yue Chen, Shaozhi Fu · 2020 · International Journal of Pharmaceutics
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
Andy Göbel, Valentina M. Zinna, S. Dell'Endice, Nikolai Jaschke, Jan Dominik Kuhlmann, Pauline Wimberger, Tilman D. Rachner · 2020 · BMC Cancer
Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
Jingchao Liu, Hong Ma, Lingfeng Meng, Xiaodong Liu, Zhengtong Lv, Yaoguang Zhang, Jianye Wang · 2021 · Frontiers in Molecular Biosciences
MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis
Liang Xiang, Qinghai Zeng, Jianye Liu, Mengqing Xiao, Dong He, Qun Zhang, Dan Xie, Minhua Deng, Yuxing Zhu, Yan Liu et al. · 2021 · 中国科学通报：英文版
Pyroptosis, a New Breakthrough in Cancer Treatment
Dengqiang Wu, Changhong Wei, Yujie Li, Xuejia Yang, Sufang Zhou · 2021 · Frontiers in Oncology
MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer
Ruiguang Zhang, Yan Li, Xiaochuan Dong, Li Peng, Xiu Nie · 2014 · Medical Oncology
Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer
Hua Shen, Jianxin Shen, Lin Wang, Zhumei Shi, Min Wang, Bing‐Hua Jiang, Yongqian Shu · 2014 · Biomedicine & Pharmacotherapy
Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs
Ida Ritacco, Gloria Mazzone, Nino Russo, Emilia Sicilia · 2016 · Inorganic Chemistry
A Novel Platinum–Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway
Sonia Aroui, Lucie Dardevet, Wafa Ben Ajmia, Madryssa de Boisvilliers, Florian Perrin, Amel Laajimi, Ahcène Boumendjel, Abderraouf Kénani, Müller Jm, Michel MDW DE WAARD · 2015 · Molecular Pharmaceutics
Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury
Di Huang, Chuangyuan Wang, Yingjie Duan, Qiang Meng, Zhihao Liu, Xiaokui Huo, Huijun Sun, Xiaodong Ma, Kexin Liu · 2017 · Toxicology and Applied Pharmacology